Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# Sitemap is also available on /sitemap.xml Sitemap: https://www.rippletherapeutics.com/sitemap.xml User-agent: |
Title | Ripple |
Description | Keeping Patients in The Ripple Therapeutics’ Epidel technology is founded on a discovery that drugs can be engineered into controlled release Pharmaceuticals and Medical Device Coatings without the use of polymers or excipients. Our lead product (IBE-814 IVT) is a |
Keywords | Ripple Therapeutics, Epidel, intravitreal implants, microparticles, nanoparticles, medical device coatings, proprietary prodrug, new chemical entity |
WebSite | rippletherapeutics.com |
Host IP | 107.21.8.129 |
Location | United States |
Site | Rank |
US$3,184,681
Last updated: 2023-04-29 10:43:32
rippletherapeutics.com has Semrush global rank of 3,323,505. rippletherapeutics.com has an estimated worth of US$ 3,184,681, based on its estimated Ads revenue. rippletherapeutics.com receives approximately 367,464 unique visitors each day. Its web server is located in United States, with IP address 107.21.8.129. According to SiteAdvisor, rippletherapeutics.com is safe to visit. |
Purchase/Sale Value | US$3,184,681 |
Daily Ads Revenue | US$2,940 |
Monthly Ads Revenue | US$88,192 |
Yearly Ads Revenue | US$1,058,294 |
Daily Unique Visitors | 24,498 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
rippletherapeutics.com. | A | 900 | IP: 107.21.8.129 |
rippletherapeutics.com. | NS | 900 | NS Record: ns2.hover.com. |
rippletherapeutics.com. | NS | 900 | NS Record: ns1.hover.com. |
rippletherapeutics.com. | MX | 888 | MX Record: 10 interfacebiologics.in.tmes.trendmicro.com. |
rippletherapeutics.com. | TXT | 900 | TXT Record: oH+pM+kSa/4xwM7nSzIbQrWbwA01l3tYcy19GyNyIJd6G+oyYOBivffmhQRs3ydAtGUHgLWX2wmT/zUxGfHv4A== |
rippletherapeutics.com. | TXT | 900 | TXT Record: v=spf1 ip4:38.116.199.20 ip4:38.116.199.21 a:mail.interfacebiologics.com a:owa.interfacebiologics.com mx include:spf.protection.outlook.com -all |
rippletherapeutics.com. | TXT | 900 | TXT Record: MS=ms66774959 |
rippletherapeutics.com. | TXT | 900 | TXT Record: hes=a28c5b50b6b5e3ecbad0e885d391d9eb |
Our Science About News Careers Contact Get in touch (416) 673-8170 busdev@rippletherapeutics.com Keeping Patients in Sight We see new ways to deliver drugs Ripple is a clinical stage ophthalmic therapeutics company focused on sustained drug delivery without the use of polymers or excipients. Our novel therapeutics provide for better outcomes for patients, easier management of care for physicians and lower costs for payors. Ripple’s Discovery Epidel™ is founded on a discovery that drugs can be designed to deliver themselves without the need for polymers or excipients. Epidel™ prodrug materials are readily manufactured into implantable forms like cylinders and microspheres. Drug dissolves from the surface of the implant via surface erosion in a highly predictable manner: dose is dictated by implant surface area; duration by implant diameter. The result is an ability to finely tune pharmacokinetics to meet the needs of a target indication with precision control of drug dosing without the |
HTTP/1.1 301 Moved Permanently Server: nginx/1.16.1 Date: Fri, 22 Oct 2021 09:17:09 GMT Content-Type: text/html Content-Length: 169 Connection: keep-alive Location: https://www.rippletherapeutics.com/ HTTP/2 200 date: Fri, 22 Oct 2021 09:01:51 GMT content-type: text/html;charset=UTF-8 content-length: 72792 set-cookie: AWSALB=eRQKBWxmwavi4NZ0Unh5InMIPFvvm5Q2fdNrsiS8JwpOrqkGYeuCh87uFaJZdc0oJi1ags+4CZxmNcEVSUgvY0p+Uq/E2Bdti0KMJgGbg9fTuS1LKanWO5Kx6k03; Expires=Fri, 29 Oct 2021 09:01:50 GMT; Path=/ set-cookie: AWSALBCORS=eRQKBWxmwavi4NZ0Unh5InMIPFvvm5Q2fdNrsiS8JwpOrqkGYeuCh87uFaJZdc0oJi1ags+4CZxmNcEVSUgvY0p+Uq/E2Bdti0KMJgGbg9fTuS1LKanWO5Kx6k03; Expires=Fri, 29 Oct 2021 09:01:50 GMT; Path=/; SameSite=None; Secure server: Apache/2.4.46 (Ubuntu) ff-cache: c300|dc21/09/23:10/10/16|h4045|i1865 etag: ID1865 last-modified: Thu, 23 Sep 2021 14:10:16 GMT ff-version: 5.4.20 ff-cachecontrol: 0,ff-cache,ff-c-3-0-0|no-cache,no-store,max-age=0 cache-control: no-cache,no-store,max-age=0 strict-transport-security: max-age=31536000; includeSubdomains ff-pid: 200_992A59F378079398F098753A52BD1E25 ff-info: i211015114043:7a1fe88ef327c44d,v content-language: en set-cookie: cfid=eb38de86-683e-4071-92e6-522fd21a6e22;Path=/;Expires=Thu, 11-Nov-2021 10:41:32 UTC;HTTPOnly set-cookie: cftoken=0;Path=/;Expires=Thu, 11-Nov-2021 10:41:32 UTC;HTTPOnly set-cookie: SAMESITE=Lax;Path=/ set-cookie: JSESSIONID=A1D685614F23C3193B24673E29DF653D;path=/;HttpOnly x-powered-by: Innovasium/iCMS-Ramsay1 x-powered-by-type: Live |
Domain Name: RIPPLETHERAPEUTICS.COM Registry Domain ID: 2420749706_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.tucows.com Registrar URL: http://www.tucows.com Updated Date: 2019-11-14T17:54:02Z Creation Date: 2019-08-07T00:47:36Z Registry Expiry Date: 2022-08-07T00:47:36Z Registrar: Tucows Domains Inc. Registrar IANA ID: 69 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.HOVER.COM Name Server: NS2.HOVER.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-11T00:31:32Z <<< |